Trial Profile
Phase III bridge study of aerosolised sinapultide
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Sinapultide (Primary)
- Indications Neonatal respiratory distress syndrome
- Focus Therapeutic Use
- 23 Jul 2018 According to a Windtree Therapeutics media release, the company is planning to initiate bridge study with the ADS in Q4 of 2018.
- 13 Nov 2013 New trial record